Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer

2 Visualizações
administrator
administrator
07/14/23

David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).

More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance

  • Categoria

Mostre mais

0 Comentários Ordenar por

Nenhum comentário encontrado

Comentários do Facebook

A seguir